Characteristics and barriers to care for people with and without social security undergoing renal replacement therapy in Mexico City
DOI:
https://doi.org/10.17533.udea.rfnsp.e356078Keywords:
barriers to care, chronic kidney disease, social security, renal replacement therapyAbstract
Objective: To describe the characteristics of people with chronic kidney disease on renal replacement therapy (dialysis or hemodialysis), with and without social security, as well as the barriers to care they experienced. Metodología: Data were collected between June 2019 and February 2020, in three tertiary care hospitals in Mexico City. A total of 163 people on renal replacement therapy were surveyed. Frequencies and percentages were used to report the results.
Results: Slightly more than half of the people had no social security and the median age was 56 years. In 40.0% of the cases, the diagnosis of chronic kidney disease was made by a family physician or general practitioner. The most common renal replacement therapy among the population without social security was intermittent hemodialysis (72.6%), while for those with social security it was continuous ambulatory peritoneal dialysis (72.2%). 31.0% of people without social security did not receive the recommended renal replacement therapy sessions. Conclusions: People faced barriers to chronic kidney disease care regardless of their social security status; however, the barriers were more accentuated for people without social security. Moreover, people without social security had access to worse therapeutic regimens, as they frequently received suboptimal treatment.
Downloads
References
1. Correa-Rotter R, Méndez Durán A, Vallejos A, et al. Unmet needs of CKD in Latin America: A review from expert virtual working group. Kidney Int Rep. 2023;8(5):954-67. DOI: https://doi.org/10.1016/j.ekir.2023.02.1082
2. García-García G, Chavez-Iñiguez JS. The tragedy of having ESRD in Mexico. Kidney Int Rep. 2018;3(5):1027-9. DOI: https://doi.org/10.1016/j.ekir.2018.07.018
3. Agudelo-Botero M, Valdez-Ortiz R, Giraldo-Rodríguez L, et al. Overview of the burden of chronic kidney disease in Mexico: Secondary data analysis based on the Global Burden of Disease Study 2017. BMJ Open. 2020;10(3):e035285. DOI: https://doi.org/10.1136/bmjopen-2019-035285
4. Argaiz ER, Morales-Juárez L, Razo C, et al. La carga de enfermedad renal crónica en México. Análisis de datos basado en el estudio Global Burden of Disease 2021. Gac Med Mex. 2023;159(6):487-93. DOI: https://doi.org/10.24875/gmm.23000393
5. Institute for Health Metrics and Evaluation (IHME). GBD compare data visualization [internet]. 2019 [citado 2024 feb. 13]. Disponible en: https://vizhub.healthdata.org/gbd-compare/
6. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709-33. DOI: https://doi.org/10.1016/S0140-6736(20)30045-3
7. Instituto Nacional de Salud Pública (INSP). Encuesta Nacional de Salud y Nutrición 2022 [internet]. 2023 [citado 2023 dic. 02]. Disponible en: https://ensanut.insp.mx/encuestas/ensanutcontinua2022/documentos_analiticos.php
8. Kierans C, Padilla-Altamira C, Garcia-Garcia G, et al. When health systems are barriers to health care: Challenges faced by uninsured Mexican kidney patients. PLoS One. 2013;8(1):e54380. DOI: https://doi.org/10.1371/journal.pone.0054380
9. Tamayo J. Implicaciones de la erc para pacientes, familias y sociedad. En: Tamayo J, Lastiri HS. La enfermedad renal crónica en México. Hacia una política nacional para enfrentarla. México: Intersistemas S. A. de C. V. [internet]; 2016. pp. 19-22. [citado 2023 dic. 14]. https://www.anmm.org.mx/pdf/publicaciones/ultimas_publicaciones/ENF-RENAL.pdf
10. Agudelo-Botero M, González-Robledo MC, Reyes-Morales H, et al. Health care trajectories and barriers to treatment for patients with end-stage renal disease without health insurance in Mexico: A mixed methods approach. Int J Equity Health. 2020;19(1):90. DOI: https://doi.org/10.1186/s12939-020-01205-4
11. López-Cervantes M, Rojas-Russell ME, Tirado-Gómez LL, et al. Enfermedad renal crónica y su atención mediante tratamiento sustitutivo en México. Ciudad de México: Facultad de Medicina, Universidad Nacional Autónoma de México; 2009.
12. Mejía-Avila RE, Arredondo A, De la Sierra de la Vega LA, et al. Barriers and facilitators in timely detection of chronic kidney disease: Evidences for decision-makers. Arch Med Res. 2020(5):355-62. DOI: https://doi.org/10.1016/j.arcmed.2020.04.009
13. Amato JD. Grandes retos de la enfermedad renal crónica en México. En: Tamayo J, Lastiri HS. La enfermedad renal crónica en México. Hacia una política nacional para enfrentarla. México: Intersistemas S. A. de C. V. [internet]; 2016. pp. 39-48. [citado 2023 dic. 14]. https://www.anmm.org.mx/pdf/publicaciones/ultimas_publicaciones/ENF-RENAL.pdf
14. Redacción El Economista. Gasto público en salud: recursos en México cayeron 3.4% en 2023. El Economista [internet] 2024 feb. 19 [citado 2024 may. 5]. Disponible en: https://www.eleconomista.com.mx/economia/Gasto-publico-en-salud-Recursos-en-Mexico-cayeron-3.4-en-2023-20240219-0074.html
15. International Society of Nephrology. KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease [internet]. 2013 [citado 2023 dic. 14]. Disponible en: https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf
16. StataCorp. Stata Statistical Software: Release 17. College Station, TX: StataCorp LLC; 2021.
17. Figueroa-Lara A, Gonzalez-Block MA, Alarcon-Irigoyen J. Medical expenditure for chronic diseases in Mexico: The case of selected diagnoses treated by the largest care providers. PLoS One. 2016;11(1):e0145177. DOI: https://doi.org/10.1371/journal.pone.0145177
18. Quiñones J, Hammad Z. Social determinants of health and chronic kidney disease. Cureus. 2020;12(9):e10266. DOI: https://doi.org/10.7759/cureus.10266
19. Valdez Ortiz R, Escorza-Valdivia S, Benitez-Renteria S, et al. Factors of poor prognosis associated with chronic kidney disease by stage in ambulatory patients: A cross-sectional study. Arch Med Res. 2022;53(5):524-32. DOI: https://doi.org/10.1016/j.arcmed.2022.06.005
20. Valdez-Ortiz R, Navarro-Reynoso F, Olvera-Soto MG, et al. Mortality in patients with chronic renal disease without health insurance in Mexico: Opportunities for a national renal health policy. Kidney Int Rep. 2018;3(5):1171-82. DOI: https://doi.org/10.1016/j.ekir.2018.06.004
21. Crews DC, Bello AK, Saadi G. Burden, access, and disparities in kidney disease. Clin Nephrol. 2019;91(3):129-37. DOI: https://doi.org/10.5414/CN91WKDEDI
22. Arce-Moguel FE, García-Chong NR, Salvatierra-Izaba BE. Los desafíos de la enfermedad renal crónica en México (2000-2018). Quintana Roo: El Colegio de la Frontera Sur; 2022.
23. Kalantar-Zadeh K, Kam-Tao Li P, Tantisattamo E, et al. Living well with kidney disease by patient and care-partner empowerment: Kidney health for everyone everywhere. Clin Nephrol. [internet]. 2021;95(3):115-22. DOI: https://doi.org/10.5414/cn110436
24. Anandh U, Meena P, et al. Social, political and legal determinants of kidney health: Perspectives from lower-and middle-income countries with a focus on India. Front. Nephrol. 2022;2:1024667. DOI: https://doi.org/10.3389/fneph.2022.1024667
25. Neuen BL, Chadban SJ, Demaio AR, et al. Editorial. Chronic kidney disease and the global NCDs agenda. BMJ Glob Health. 2017;2(2):e000380. DOI: https://doi.org/10.1136/bmjgh-2017-000380
26. Mercado-Martínez FJ, Correa-Mauricio ME. Viviendo con hemodiálisis y sin seguridad social: las voces de los enfermos renales y sus familias. Salud Pública Mex. 2015;57(2):155-60. DOI: https://doi.org/10.21149/spm.v57i2.7411
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Universidad de Antioquia
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The contents of the articles are the responsibility of the authors
The editorial committee has editorial independence from the National School of Public Health "Héctor Abad Gómez" of the University of Antioquia.
The editorial committee is not responsible for aspects related to copying, plagiarism or fraud that may appear in the articles published in it.
When you are going to reproduce and disclose photographs or personal data in printed or digital format, informed consent is required. Therefore, this requirement is required of the author at the time of receipt of the manuscript.
Authors are responsible for obtaining the necessary permissions to reproduce any material protected by reproduction rights.
The authors preserve the moral rights and assign the economic rights that will correspond to the University of Antioquia, to publish it, distribute electronic copies, include them in indexing services, directories or national and international databases in Open Access, under the Creative Commons Attribution license -Not Commercial-Share Equal 4.0 International Commercial (CC BY-NC-SA) which allows others to distribute, remix, retouch, and create from the work in a non-commercial way, as long as the respective credit and license are granted. new creations under the same conditions.
The authors will sign the declaration of transfer of economic rights to the University of Antioquia, after the acceptance of the manuscript.
The editorial committee reserves the right to reject the articles whose authors do not offer satisfactory explanations about the contribution of each author, to meet the criteria of authorship in the submission letter. All authors must meet the four criteria of authorship according to ICMJE: "a) .- That there is a substantial contribution to the conception or design of the article or to the acquisition, analysis or interpretation of the data. b) That they have participated in the design of the research work or in the critical review of its intellectual content. c) .- That has been intervened in the approval of the final version that will be published.d). That they have the capacity to respond to all aspects of the article in order to ensure that issues related to the accuracy or integrity of any part of the work are adequately investigated and resolved. "
-- 
--
